In their new blog, @SeemaCMS, John Coster, and Jeet Guram of @CMSgov argue that #DrugPricing is a prime candidate for value-based reforms, given the advent of new, potentially curative medications ill-suited to fee-for-service financing. https://bit.ly/3bUcsOf